Faculty presentations from a CME symposium held at the 2019
Gastrointestinal Cancers Symposium. Featuring perspectives from Drs
Andrew E Hendifar, Eileen M O’Reilly, Philip A Philip and Margaret
A Tempero:
Available and Emerging Research Guiding the Treatment of
Resectable or Borderline Resectable Pancreatic Adenocarcinoma (PAD)
— Dr Tempero (0:00)
Patient- and Disease-Specific Factors Informing the Selection
of Therapy for Locally Advanced, Unresectable PAD; Selection of
First-Line Treatment for Metastatic Disease — Dr Philip (8:24)
Optimal Management of Metastatic Disease After Progression on
First-Line Therapy — Dr O’Reilly (17:24)
Novel Agents and Strategies Under Investigation — Dr Hendifar
(25:21)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.